Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Carisma Therapeutics Inc. (SESN) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/08/2023 4 Kelly Steven (President and CEO) has filed a Form 4 on Carisma Therapeutics Inc.
Txns: Granted 600,000 options to buy @ $7.25, valued at $4.4M
06/08/2023 4 ZWEIFACH SANFORD S (Director) has filed a Form 4 on Carisma Therapeutics Inc.
Txns: Granted 38,700 options to buy @ $7.25, valued at $280.6k
06/08/2023 4 Morris Richard Steven (CFO) has filed a Form 4 on Carisma Therapeutics Inc.
Txns: Granted 238,000 options to buy @ $7.25, valued at $1.7M
06/08/2023 4 Torok Michael (Director) has filed a Form 4 on Carisma Therapeutics Inc.
Txns: Granted 38,700 options to buy @ $7.25, valued at $280.6k
06/08/2023 4 Klichinsky Michael (Chief Scientific Officer) has filed a Form 4 on Carisma Therapeutics Inc.
Txns: Granted 238,000 options to buy @ $7.25, valued at $1.7M
06/08/2023 4 Ugwumba Chidozie (Director) has filed a Form 4 on Carisma Therapeutics Inc.
Txns: Granted 38,700 options to buy @ $7.25, valued at $280.6k
06/08/2023 4 Morrison Briggs (Director) has filed a Form 4 on Carisma Therapeutics Inc.
Txns: Granted 38,700 options to buy @ $7.25, valued at $280.6k
03/13/2023 3 ModernaTX, Inc. (10% Owner) has filed a Form 3 on Carisma Therapeutics Inc.
03/09/2023 4 Kelly Steven (President and CEO) has filed a Form 4 on Carisma Therapeutics Inc.
Txns: Granted 625,797 options to buy @ $0.63, valued at $394.3k
Granted 415,968 options to buy @ $1.46, valued at $607.3k
03/09/2023 4 Ugwumba Chidozie (Director) has filed a Form 4 on Carisma Therapeutics Inc.
Txns: Granted 2,215,877 shares @ $0
03/09/2023 4 Hodits Regina (Director) has filed a Form 4 on Carisma Therapeutics Inc.
Txns: Granted 2,297,546 shares @ $0
03/09/2023 4 Klichinsky Michael (Chief Scientific Officer) has filed a Form 4 on Carisma Therapeutics Inc.
Txns: Granted 484,347 shares @ $0
Granted 56,982 options to buy @ $0.11, valued at $6.3k
Granted 75,976 options to buy @ $0.63, valued at $47.9k
Granted 112,064 options to buy @ $1.46, valued at $163.6k
03/09/2023 4 Morris Richard Steven (CFO) has filed a Form 4 on Carisma Therapeutics Inc.
Txns: Granted 331,114 options to buy @ $1.46, valued at $483.4k
03/09/2023 4 Torok Michael (Director) has filed a Form 4 on Carisma Therapeutics Inc.
Txns: Granted 51,250 shares @ $0
Granted 319,991 shares @ $0
Granted 50,000 shares @ $0
03/09/2023 4 ZWEIFACH SANFORD S (Director) has filed a Form 4 on Carisma Therapeutics Inc.
Txns: Granted 413 shares @ $0
Granted 184,621 options to buy @ $1.46, valued at $269.5k
03/09/2023 4 Morrison Briggs (Director) has filed a Form 4 on Carisma Therapeutics Inc.
Txns: Granted 12,175 shares @ $0
Granted 63,310 options to buy @ $0.68, valued at $43.1k
Granted 34,189 options to buy @ $1.46, valued at $49.9k
03/09/2023 3 Kelly Steven (President and CEO) has filed a Form 3 on Carisma Therapeutics Inc.
03/09/2023 3 Ugwumba Chidozie (Director) has filed a Form 3 on Carisma Therapeutics Inc.
03/09/2023 3 Hodits Regina (Director) has filed a Form 3 on Carisma Therapeutics Inc.
03/09/2023 3 Klichinsky Michael (Chief Scientific Officer) has filed a Form 3 on Carisma Therapeutics Inc.
03/09/2023 3 Morris Richard Steven (CFO) has filed a Form 3 on Carisma Therapeutics Inc.
03/09/2023 3 Torok Michael (Director) has filed a Form 3 on Carisma Therapeutics Inc.
03/09/2023 3 ZWEIFACH SANFORD S (Director) has filed a Form 3 on Carisma Therapeutics Inc.
03/09/2023 3 Odlander Bjorn (Director) has filed a Form 3 on Carisma Therapeutics Inc.
03/09/2023 3 Morrison Briggs (Director) has filed a Form 3 on Carisma Therapeutics Inc.
03/06/2023 4 Sullivan Mark (General Counsel & Secretary) has filed a Form 4 on Sesen Bio, Inc.
Txns: Sold 100,978 shares @ $0.587, valued at $59.3k
Exercised 185,000 shares @ $0.587, valued at $108.6k
Sold 73,361 shares @ $0.587, valued at $43.1k
Exercised 113,175 shares @ $0.587, valued at $66.4k
Sold 44,879 shares @ $0.587, valued at $26.3k
03/06/2023 4 MacDonald Glen C (Chief Technology Officer) has filed a Form 4 on Sesen Bio, Inc.
Txns: Sold 76,247 shares @ $0.587, valued at $44.8k
Exercised 183,317 shares @ $0.587, valued at $107.6k
Sold 60,237 shares @ $0.587, valued at $35.4k
Exercised 102,975 shares @ $0.587, valued at $60.4k
Sold 33,888 shares @ $0.587, valued at $19.9k
03/06/2023 4 Ryu Elly (Principal Accounting Officer) has filed a Form 4 on Sesen Bio, Inc.
Txns: Sold 17,289 shares @ $0.587, valued at $10.1k
03/06/2023 4 Cannell Thomas R (President and CEO) has filed a Form 4 on Sesen Bio, Inc.
Txns: Sold 208,923 shares @ $0.587, valued at $122.6k
Exercised 606,800 shares @ $0.587, valued at $356.2k
Sold 278,564 shares @ $0.587, valued at $163.5k
03/06/2023 4 Forbes Monica (CFO) has filed a Form 4 on Sesen Bio, Inc.
Txns: Sold 154,266 shares @ $0.587, valued at $90.6k
Exercised 190,375 shares @ $0.587, valued at $111.8k
Sold 93,279 shares @ $0.587, valued at $54.8k
Exercised 180,750 shares @ $0.587, valued at $106.1k
Sold 98,304 shares @ $0.587, valued at $57.7k
02/23/2023 4 Sullivan Mark (General Counsel & Secretary) has filed a Form 4 on Sesen Bio, Inc.
Txns: Sold 39,831 shares @ $0.5873, valued at $23.4k
02/23/2023 4 Ryu Elly (Principal Accounting Officer) has filed a Form 4 on Sesen Bio, Inc.
Txns: Sold 7,159 shares @ $0.5873, valued at $4.2k
02/23/2023 4 Cannell Thomas R (President and CEO) has filed a Form 4 on Sesen Bio, Inc.
Txns: Sold 53,727 shares @ $0.5873, valued at $31.6k
02/23/2023 4 Forbes Monica (CFO) has filed a Form 4 on Sesen Bio, Inc.
Txns: Sold 61,862 shares @ $0.5873, valued at $36.3k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy